CD26 costimulatory blockade improves lung allograft rejection and is associated with enhanced interleukin-10 expression

CD26 costimulatory blockade promotes lung allograft acceptance via reduced T cell infiltration, less expression of IL-17, and increased expression of IL-10, likely to be derived from alternatively activated macrophages.